help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism Vol. 50, No. 1 33-39
doi:10.1210/jcem-50-1-33
Copyright © 1980 by the Endocrine Society.
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by BERGER, D.
Right arrow Articles by FAJANS, S. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by BERGER, D.
Right arrow Articles by FAJANS, S. S.

The Effect of Adrenergic Receptor Blockade on the Exercise-Induced Rise in Pancreatic Polypeptide in Man*

DAVID BERGER, JOHN C. FLOYD, JR.,, RICHARD M. LAMPMAN and STEFAN S. FAJANS

Department of Internal Medicine, Division of Endocrinology and Metabolism and the Metabolism Research Unit, and the Division of Cardiology, The University of Michigan Ann Arbor, Michigan 48109

Address requests for reprints to: John C. Floyd, Jr., M.D., C7009 University Hospital, Ann Arbor, Michigan 48109.

The effect of adrenergic receptor-blocking agents upon plasma levels of human pancreatic polypeptide (hPP), human GH (hGH), immunoreactive insulin, and glucose during graded submaximal exercise was ascertained in six healthy nonobese males. Subjects exercised from 0–27 min on a motor-driven treadmill and received infusions from –10 to 40 min of either 1) saline, 2) saline plus phentolamine (0.5 mg/min; {alpha}-adrenergic blockade), or 3) propranolol (3 mg) from –10 to –5 min, followed by saline plus propranolol (0.08 mg/min; β-adrenergic blockade).

During saline-exercise, mean plasma hPP rose from a mean (±SE) basal level of 45 ± 11 to 149 ± 51 pg/ml at 27 min, whereas with phentolamine-exercise, the maximal level reached by mean plasma hPP (305 ± 28 pg/ml) was significantly greater than that with saline (P < 0.05). During propranolol-exercise, mean plasma hPP did not rise significantly above the basal level. The incremental area under the hPP curve for phentolamine-exercise also was significantly greater than that for saline-exercise or propranolol-exercise. The changes in plasma hGH during and after saline-exercise correlated with those of hPP, but the effects of phentolamine and propranolol upon exercise-induced increases in hGH were opposite to the effects upon hPP. The exerciseinduced fall in immunoreactive insulin was accentuated with propranolol and abolished with phentolamine.

It is concluded that 1) submaximal exercise stimulates secretion of hPP and hGH, 2) adrenergic mechanisms participate in exercise-induced increased secretion of hPP (β-adrenergic stimulation augments secretion and a-adrenergic stimulation inhibits secretion), and 3) adrenergic effects which modulate exerciseinduced secretion of hPP and insulin are in parallel but are opposite to those that modulate the secretion of hGH.

* This work was supported in part by USPHS NIAMDD Grants AM-02244, AM-00888, AM-20572, and TI AM-05001; the American Diabetes Association-Michigan Affiliate; The Upjohn Co. (Kalamazoo, MI); Pfizer, Inc. (New York, NY); and the Eli Lilly Co. (Indianapolis, IN). Preliminary aspects of this study were reported in abstract form at the 38th Annual Meeting of the American Diabetes Association, Boston, MA, June 11–13, 1978.

Received June 5, 1979.




This article has been cited by other articles:


Home page
DiabetesHome page
S. Bao, V. J. Briscoe, D. B. Tate, and S. N. Davis
Effects of Differing Antecedent Increases of Plasma Cortisol on Counterregulatory Responses During Subsequent Exercise in Type 1 Diabetes
Diabetes, September 1, 2009; 58(9): 2100 - 2108.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
R. H. Coker, Y. Koyama, D. B. Lacy, P. E. Williams, N. Rheaume, and D. H. Wasserman
Pancreatic innervation is not essential for exercise-induced changes in glucagon and insulin or glucose kinetics
Am J Physiol Endocrinol Metab, December 1, 1999; 277(6): E1122 - E1129.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
R. Omdal, R. Jorde, S. I. Mellgren, and G. Husby
Autonomic Function in Systemic Lupus Erythematosus
Lupus, October 1, 1994; 3(5): 413 - 417.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1980 by The Endocrine Society